Pop Parliament TRIPS up Pro-industry agreements, dampens emerging markets
This article was originally published in Scrip
Executive Summary
Flushed from their success in blocking the Anti-Counterfeiting Trade Agreement (ACTA), key political groups from the European Parliament's are now turning their attention to other EU trade agreements that might threaten access to medicines in emerging markets and developing countries. Representatives of three separate European parliamentary groups have told Scrip that they would be looking out for anything in European Commission proposals on trade that might limit poorer nations' access to healthcare products, including so-called TRIPS Plus measures.